26.65
전일 마감가:
$26.94
열려 있는:
$26.41
하루 거래량:
331.51K
Relative Volume:
0.43
시가총액:
$972.67M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-7.67%
1개월 성능:
-6.31%
6개월 성능:
+136.01%
1년 성능:
+13.21%
Rapport Therapeutics Inc Stock (RAPP) Company Profile
명칭
Rapport Therapeutics Inc
전화
857-321-8020
주소
99 HIGH STREET, BOSTON
RAPP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
RAPP
Rapport Therapeutics Inc
|
26.65 | 1.24B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-16 | 개시 | Truist | Buy |
| 2025-08-06 | 개시 | H.C. Wainwright | Buy |
| 2025-04-08 | 개시 | Citizens JMP | Mkt Outperform |
| 2024-07-02 | 개시 | Jefferies | Buy |
| 2024-07-02 | 개시 | Stifel | Buy |
| 2024-07-02 | 개시 | TD Cowen | Buy |
모두보기
Rapport Therapeutics Inc 주식(RAPP)의 최신 뉴스
What institutional flow reveals about Rapport Therapeutics Inc.Trade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
Can trapped investors hope for a rebound in Rapport Therapeutics Inc.Portfolio Return Summary & Accurate Entry/Exit Alerts - newser.com
Has Rapport Therapeutics Inc. formed a bullish divergence2025 Short Interest & Real-Time Volume Trigger Notifications - newser.com
Rapport Therapeutics, Inc. (NASDAQ:RAPP) Short Interest Down 33.3% in October - MarketBeat
Using R and stats models for Rapport Therapeutics Inc. forecastingMarket Performance Summary & Proven Capital Preservation Tips - newser.com
Historical volatility pattern of Rapport Therapeutics Inc. visualizedGold Moves & Real-Time Chart Breakout Alerts - newser.com
Rapport Therapeutics Inc expected to post a loss of 78 cents a shareEarnings Preview - TradingView
Analyzing Rapport Therapeutics Inc. with risk reward ratio charts2025 Pullback Review & Long Hold Capital Preservation Tips - newser.com
How to recover losses in Rapport Therapeutics Inc. stock2025 Year in Review & Momentum Based Trading Ideas - newser.com
Why Rapport Therapeutics Inc. stock is a value investor pickJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - newser.com
What earnings revisions data tells us about Rapport Therapeutics Inc.July 2025 Opening Moves & Free Weekly Watchlist of Top Performers - newser.com
What candlestick patterns are forming on Rapport Therapeutics Inc.Trade Volume Report & Daily Technical Stock Forecast Reports - newser.com
Will Rapport Therapeutics Inc. benefit from macro trendsWeekly Earnings Recap & Risk Adjusted Buy/Sell Alerts - newser.com
Tools to monitor Rapport Therapeutics Inc. recovery probabilityTrade Exit Summary & Real-Time Market Sentiment Reports - newser.com
Rapport Therapeutics’ RAP-219 Study: A Potential Game-Changer for Bipolar I Disorder - MSN
Rapport Therapeutics (RAPP) Expected to Announce Earnings on Thursday - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 8.1%Still a Buy? - MarketBeat
Is Rapport Therapeutics Inc a good long term investmentEconomic Indicators Overview & Outstanding Return Portfolio - earlytimes.in
Published on: 2025-10-28 05:44:22 - newser.com
Rapport Therapeutics Inc (RAPP) 재무 분석
Rapport Therapeutics Inc (RAPP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Rapport Therapeutics Inc 주식 (RAPP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham | Chief Executive Officer |
Oct 15 '25 |
Sale |
25.81 |
5,833 |
150,541 |
579,579 |
| Ceesay Abraham | Chief Executive Officer |
Oct 15 '25 |
Sale |
25.81 |
5,083 |
131,189 |
41,061 |
자본화:
|
볼륨(24시간):